AI assistant
Sending…
Medivir — Director's Dealing 2021
Dec 1, 2021
3177_iss_2021-12-01_62d00265-bbd0-4361-84bc-71cfce783c59.pdf
Director's Dealing
Open in viewerOpens in your device viewer

Issuer Medivir Aktiebolag
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
Instrument
| Instrument | Aktier | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Date | 30/11/2021 | |
| Limit for number of shares 10 % | ||
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity |
Shares 5,582,196
| Directly held voting rights 0 | |
|---|---|
| Indirectly held voting rights 5,582,196 | |
| Percentage |
Directly held shares 10.01549 % Directly held voting rights 0 % Indirectly held voting rights 10.01549 %
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 10.01549 % | 5,582,196 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 10.01549 % | 5,582,196 |
Group total holdings
Voting rights 5,582,196 Percentage of voting rights 10.01549
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har förvärvat de aktuella aktierna.
Published
01/12/2021 14:59
Contact
Name Magnus Westerman
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Medivir
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Quarterly Report
2026
May 5
Quarterly Report
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Annual Report (ESEF)
2026
Apr 1
Major Shareholding Notification
2026
Mar 2